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Chronic wasting disease (CWD) is the transmissible spongiform 
encephalopathy (TSE) of North American deer, elk, and moose (1). 
The TSEs are fatal neurodegenerative disorders thought to be caused 
by an infectious prion agent composed of a misfolded variant (PrPd) 
of the normally occurring host cellular prion protein (PrPc) (2). 
Misfolding of the host PrPc by exogenous or sporadically misfolded 
PrPd initiates the disease process (2). Control of CWD in elk in the 
United States (US) and Canada includes depopulation or permanent 
quarantine of infected farmed herds and culling of free-ranging 
suspects showing clinical signs. Despite these efforts, new outbreaks 
are reported in both the US and Canada (3,4) and the economic 
losses to the industry and regulatory bodies are substantial. The 
management of herds with a small number of animals introduced 
from infected farms is a concern. Introduction of an animal from an 
infected farm is a risk factor for CWD in animals housed together, 
with substantial increase in risk if the introduced animal developed 
clinical disease (4). An additional risk factor includes the normal 
prion protein precursor (PRNP) genotype, with a lower risk of dis-
ease in some populations for elk homozygous or heterozygous for 
the version of the PRNP gene which encodes a leucine residue at 
position 132 (132L) (5,6).
Levels of tissue minerals known to bind PrPc are associated with 
TSEs in several model systems. The association between TSE and 
copper (Cu) or manganese (Mn) has been reported (7,8); both of these 
minerals bind PrPc and may affect the efficiency of protein misfolding 
(9). Elevated Mn levels in brain and blood have been reported with 
bovine, ovine, and human TSEs (7,8,10). Additional divalent cations 
of appropriate size and ionic strength may also have roles in TSEs, 
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Abs t r a c t
Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy (TSE) of Rocky Mountain elk in North America. 
Recent studies suggest that tissue and blood mineral levels may be valuable in assessing TSE infection in sheep and cattle. The 
objectives of this study were to examine baseline levels of copper, manganese, magnesium, zinc, selenium, and molybdenum 
in the brains of Rocky Mountain elk with differing prion genotypes and to assess the association of mineral levels with CWD 
infection. Elk with leucine at prion position 132 had significantly lower magnesium levels than elk with 2 copies of methionine. 
Chronic wasting disease-positive elk had significantly lower magnesium than control elk. The incorporation of manganese 
levels in addition to magnesium significantly refined explanatory ability, even though manganese alone was not significantly 
associated with CWD. This study demonstrated that mineral analysis may provide an additional disease correlate for assessing 
CWD risk, particularly in conjunction with genotype.
Résumé
La maladie du dépérissement chronique (CWD) est une encéphalopathie spongiforme transmissible (TSE) des wapitis en Amérique du Nord. 
Des études récentes suggèrent que la mesure des taux de minéraux dans les tissus et le sang seraient utiles pour évaluer une infection par TSE 
chez les moutons et les bovins. Les objectifs de la présente étude étaient d’examiner les niveaux de base de cuivre, manganèse, magnésium, 
zinc, sélénium et molybdène dans le cerveau de wapitis avec des génotypes différents de sensibilité envers les maladies à prions et d’évaluer 
l’association des niveaux de minéraux avec l’infection CWD. Les wapitis avec une leucine à la position 132 du prion présentaient des niveaux 
significativement plus faibles de magnésium que les wapitis avec deux copies de méthionine. Les wapitis positifs pour CWD avaient des 
niveaux de magnésium significativement plus faibles que les wapitis témoins. L’ajout des niveaux de manganèse à ceux du magnésium a 
permis de raffiner significativement la capacité d’explication, même si le manganèse seul n’était pas associé significativement avec le CWD. 
Cette étude démontre que l’analyse des minéraux peut fournir un corrélat additionnel pour évaluer le risque de CWD, particulièrement en 
conjonction avec le génotype.
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although it is not known whether these mineral level changes reflect 
a predisposing influence on prion protein folding or a downstream 
effect of the disease processes (11). Baseline data on mineral levels 
in the brain of Rocky Mountain elk (Cervus elaphus nelsoni) are not 
available, and the confounding effects of varying feed sources and 
PRNP genotypes are not known. The objectives of this study were 
to provide baseline data on mineral levels in brain tissue from elk 
collected during regulatory depopulation of infected herds, to esti-
mate mineral levels in elk of different genotypes without evidence of 
disease, and to explore potential associations between tissue mineral 
concentrations and presence of CWD in captive Rocky Mountain elk.
Tissue samples were collected from 223 Rocky Mountain elk 
that were euthanized as part of a joint federal and state control 
program. Elk originated from 3 United States farms, each of which 
had multiple confirmed cases of CWD. Brains, tonsils, retropharyn-
geal lymph nodes and sometimes liver were collected at necropsy. 
DNA was extracted from frozen liver or brain and the open read-
ing frame of the gene for PRNP was amplified and sequenced (5). 
Genotypes at amino acid position 132 were recorded as 132MM 
(2 copies of methionine) or 132Lx (at least one copy of leucine) (5). 
Brain, retropharyngeal lymph node, and tonsil were formalin fixed 
and processed for detection of PrPd by an automated monoclonal 
antibody immunohistochemistry assay (12). Animals were con-
sidered CWD positive if at least one tissue was positive for PrPd. 
Because of the unknown lag between infection and appearance of 
detectable PrPd (4), elk exposed to CWD but lacking detectable PrPd 
were not defined as CWD negative; these animals were defined as 
herd-matched controls.
Trace minerals (Cu, Mn, Mg, Zn, Se, and Mo) were analyzed in 
samples from the cerebrum, parietal lobe, or optic lobe of the brain 
collected at necropsy. For Cu, Mn, and Zn analyses, the tissues were 
dried, weighed, ashed overnight in a muffle furnace, and then dis-
solved in dilute HNO3. The solutions were then analyzed by flame 
atomic absorption spectrophotometry (FAAS) (13). Magnesium was 
measured with a slight modification: a releasing agent (lanthanum 
oxide in dilute HCl) was added to the HNO3 solutions prior to FAAS 
(13). For Se, the tissues were dried, weighed, and then digested with 
Mg(NO3)2 and concentrated HNO3 overnight on a hot plate under 
a hood. The digests were ashed in a pre-heated muffle furnace, the 
cooled ashes were dissolved in dilute HCl, and the solutions were 
analyzed by Hydride Generation FAAS (14,15). For Mo, the tissues 
were dried, weighed, ashed overnight in a muffle furnace and 
then dissolved in dilute HNO3. Palladium nitrate [Pd(NO3)2] and 
ascorbic acid matrix modifers were added to the solutions, and the 
solutions were analyzed by Graphite Furnace Atomic Absorption 
Spectrophotometry (16). All concentrations were reported in mg/g 
(dry mass basis), and standard quality control samples spiked with 
the metal under investigation were included with each analysis.
The relationships between CWD status, PRNP genotype, and min-
eral levels in the brain were evaluated using a sample of 223 Rocky 
Mountain elk from 3 US facilities with similar CWD prevalence. 
These animals were divided into 3 groups based on genotype and 
CWD status, including 132Lx genotype control elk (n = 50), 132MM 
control elk (n = 146), and 132MM CWD elk (n = 27). Because no 
132Lx animals were positive in this sample, comparisons between 
132Lx control elk (n = 50) and 132MM control animals (n = 146) were 
used to compare mineral levels of 132MM and 132Lx elk without 
detectable PrPd. Genotypic differences in cation levels in the brain 
from control elk were examined by using t-tests to compare samples 
from elk with the PRNP 132MM genotype to samples from elk with 
the 132Lx genotype. Because the samples failed preliminary tests for 
equal variance, Satterthwaite’s method was used to estimate degrees 
of freedom for t-tests.
All CWD positive elk in this study (n = 27) had 132MM genotypes; 
therefore, only 132MM samples (n = 146 samples with no detect-
able PrPd) were used as controls for CWD investigation. Samples 
from the CWD positive and the genotype-matched control elk were 
examined for differing cation levels and the results were evaluated 
using a t-test (SAS Institute, Cary, North Carolina, USA). Logistic 
regression was used to explore potential relationships between 
CWD status (response variable) and explanatory variables sex, 
location, age at death (in years), and mineral concentrations (mg/g) 
of Cu, Mg, Mn, Mo, Se, and Zn in the brain (logistic procedure in 
SAS). This analysis used an exploratory approach, and stepwise 
automated model selection procedures of the SAS logistic procedure 
were used to evaluate models including up to 9 variables and their 
interactions. Nagelkerke’s adjusted coefficient of determination was 
used to assess the fraction of variation explained by the resulting 
model. Incremental change in mineral concentrations associated with 
doubling of the odds of detecting CWD (odds ratio = 2) were used 
to interpret the final model, where each mineral concentration was 
varied while holding others constant at the mean level.
Baseline mineral data for CWD control elk are shown by genotype 
in Table 1. Brain from control elk with the 132Lx long incubation 
genotype had significantly lower mean Mg than brain from 132MM 
control elk (346.1 mg/g versus 412.2 mg/g; t = 3.17, 106 df; P = 0.002; 
Table I). None of the other minerals differed by genotype (P . 0.05; 
Table I).
Magnesium levels were lower (314.1 mg/g versus 412.2 mg/g; 
t = 3.12, 36.1 df; P = 0.004) in CWD positive elk but other minerals 
did not differ by CWD status (Table II). Logistic regression models 
were used to better explain variation in CWD status using multiple 
explanatory variables. There was little evidence of any relationship 
between CWD status and sex, location, age, and the cations Cu, Mo, 
Se, Zn (P . 0.05). The final model included levels of Mg (Wald chi-
square = 16.3, 1 df; P , 0.0001) and Mn (Wald chi-square = 10.7, 1 df; 
P = 0.001) in the brain. Combined use of Mn and Mg explained 21% 
of variation in CWD status (R2 = 0.21) compared with 10% using 
Mg alone (R2 = 0.10) indicating the value of both metals in supply-
ing complementary information. Table III shows increments of each 
cation required to double odds of detecting CWD, given the final 
model and cation levels measured from brain tissue. Each decrease of 
85 mg/g Mg doubled the odds of detecting CWD, if Mn levels were 
held constant. Similarly, each increase of 0.48 mg/g Mn doubled the 
odds of detecting CWD, if Mg levels were held constant.
The effect of PRNP genotype on baseline Mg was significant in this 
study; control elk with the 132MM short incubation genotype had 
higher Mg levels than elk with the 132Lx long incubation genotype 
from the same facilities. Since Mg plays a critical role in membrane 
stability, energy balance, oxidative stress, and neurotransmitter 
release following brain injury (17), the effect of genotype-related 
differences in baseline Mg may be of interest in understanding the 
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pathogenesis of long incubation TSE phenotypes. Magnesium levels 
in ruminant livestock are tightly regulated within a range controlled 
by diet, undefined genetic elements, and reproductive status, par-
ticularly in association with lactation (18). Although standards for 
Mg and other minerals in brain from Rocky Mountain elk are not 
reported, the levels in this study (Tables I–II) were similar to those 
reported for liver mineral levels from Tule elk (Cervus elaphus nan-
nodes) (19). Consideration of environmental and forage factors in 
association with PRNP genotype in study populations will be use-
ful in establishing baseline data on mineral levels in captive Rocky 
Mountain elk.
When only elk with the 132MM short incubation genotype were 
considered, lower Mg levels were observed in brain from CWD posi-
tive elk than in brain from control elk from the same herds. This was 
true despite the possibility that some of the control animals could 
have been very early stage positives, which would have made it 
more difficult to establish significant differences between groups. 
The finding of reduced Mg in brain from elk with natural CWD is 
consistent with a similar finding in mice experimentally infected 
with scrapie (20), which suggests that Mg reduction may be a feature 
of many TSEs. Reduced magnesium is an almost ubiquitous feature 
of central nervous system injury (17), however, and the effect is not 
likely to be specific to the TSEs.
Elevated levels of Mn in the peripheral blood may be useful as 
an early indicator of TSE infection (7,10). Because disease-causing 
PrPd accumulates most heavily in nervous tissue and especially the 
brain (12), this study examined brain tissue levels of Mn. Although 
brain tissue from CWD-positive elk had a trend toward elevated 
Mn, the relationship was weak. This finding is consistent with a 
recent report on Mn levels in the central nervous system of sheep, 
in which Mn levels in infected sheep rose within a month following 
infection (7). PrPc binds Mn at 2 sites, both of which are upstream 
from the residue 132 substitution, so a direct effect of the mutation 
on Mn binding is not predicted (9).
However, the combined model using Mn while accounting for Mg 
reveals the potential importance of Mn by quantifying the relation-
ship of Mg and Mn with detection of CWD under the conditions 
that existed in this study. Nagelkerke’s adjusted R2 suggests that 
the model with both Mn and Mg explained approximately twice as 
much variation in CWD status as the use of Mg alone. Changes in 
concentration well within the range of observed values for either 
Mg or Mn were associated with a doubling of the odds of CWD. 
Although this study detected 2 risk-associated minerals for elk of 
the 132MM genotype, it does not establish a causal link between 
Mg and Mn concentrations and CWD. However, if absolute levels 
or changes in tissue Mg and Mn concentrations are symptomatic of 
CWD, they may have practical application for herd surveillance if 
additional factors are identified to improve diagnostic precision of 
models. Because Mg levels differed between genotypes of control elk 
and because 132MM-CWD elk had similar Mg levels as 132Lx-control 
elk, it will be important to consider genotype in future studies.
Chronic wasting disease in captive elk is controlled largely by 
whole herd depopulation. However, the cost of indemnity pay-
ments, loss of animal life, and hardship to producers is considerable 
Table I. Metal concentrations in the brain and their respective standard errors from Rocky Mountain elk with 132MM and 132Lx 
genotypes in the absence of detectable PrPd (CWD control elk)
Elk genotype and CWD status Mg Mn Cu Mo Zn Se
132MM-control 412.2 1.32 12.1 0.33 39.4 0.55
n = 146 (12.3) (0.05) (.40) (0.02) (1.3) (0.01)
132Lx-control 346.1a 1.15  11.6  0.25 36.7 0.51 
n = 50 (16.8) (0.11) (0.58) (0.02) (2.2) (0.02)
Mg — magnesium; Mn — manganese; Cu — copper; Mo — molybdenum; Zn — zinc; Se — selenium.
a Different from the 132MM control elk (P = 0.002).
Table II. Metal concentrations in the brain and their respective standard errors from CWD-positive and control Rocky Mountain 
elk with the 132MM genotype
Elk genotype and CWD status Mg Mn Cu Mo Zn Se
132MM-CWD 314.1a 1.5 12.6  0.30 36.7 0.57 
n = 27 (29.0) (.011) (0.86) (0.03) (3.3) (0.03)
132MM-control 412.2 1.32  12.1 0.33 39.4 0.55 
n = 146 (12.3) (0.05) (.40) (0.02) (1.3) (0.01)
Mg — magnesium; Mn — manganese; Cu — copper; Mo — molybdenum; Zn — zinc; Se — selenium.
a Different from the 132MM control elk (P = 0.004).
Table III. Increments of magnesium and manganese associated with doubling the odds of detecting 
CWD, given the final model and cation levels measured from brain tissue
Brain cation Odds ratio 95% CI Change in cation concentration (mg/g)
Mg 2.00 − 0.35, − 0.69 − 85.0
Mn 2.00 1.34, 3.12 0.48
Mg — magnesium; Mn — manganese.
CI — confidence interval.
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and there is no assurance that the disease will not recur following 
restocking of potentially contaminated facilities (1). Mineral-based 
approaches to TSE diagnosis and pathogenesis have been proposed 
but data on baseline levels in captive Rocky Mountain elk is lacking. 
We report PRNP associated differences in Mg levels in the elk in this 
study. When PRNP genotype was held constant, Mg and Mn con-
centrations in brain tissue were related to CWD status in a logistic 
regression model. If the present results can be replicated with blood 
or some other easily accessible tissue, understanding of relative 
risk and disease course for individual animals might be enhanced 
by studies measuring changes in mineral levels after experimental 
inoculation with CWD. This study demonstrated potential for using 
multi-mineral predictors for detecting CWD and the need for addi-
tional predictors to enhance diagnostic precision.
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